TNFSF13B and rheumatoid arthritis: Use of a soluble form of TACI that antagonizes both APRIL and the closely related B-cell activation factor from the TNF family (BAFF, TNFSF13B) [16] ameliorated rheumatoid arthritis (RA) in mouse models [17-19].